Economic appraisal of vaccination against Streptoccocus agalactiae in Nile tilapia farms in Brazil

Marina K.V.C. Delphino, Rafael S.C. Barone, Carlos A.G. Leal, Henrique C.P. Figueiredo, Ian Gardner, Vítor S.P. Gonçalves

Research output: Contribution to journalArticle

Abstract

Infection with Streptococcus agalactiae causes mortality and major economic losses in Nile tilapia (Oreochromis niloticus) farming worldwide. In Brazil, serotype strains Ia, Ib and III have been isolated in streptococcosis outbreaks, but serotype Ib is the most prevalent. Vaccination is considered an effective method to prevent economically-important diseases in aquaculture and has been associated with decreased use of antibiotics and improvements in fish survival. We developed a flexible partial-budget model to undertake an economic appraisal of vaccination against Streptococcus agalactiae in Nile tilapia farmed in net cages in large reservoirs. The model considers the benefits and costs that are likely to be associated with vaccination at the farm-level, in one production cycle. We built three epidemiological scenarios of cumulative mortality attributable to S. agalactiae (5%, 10%, and 20%, per production cycle) in a non-vaccinated farm. For each scenario, we applied a stochastic model to simulate the net return of vaccination, given a combination of values of “vaccine efficacy” “gain in feed conversion ratio” “feed price” “fish market price “ and “cost of vaccine dose”. In the 20% cumulative mortality scenario, the net return would break-even (benefits ≥ costs) in at least 97.9% of interactions. Should cumulative mortality be lower than 10%, the profitability of vaccination would be more dependent on better feed conversion ratio. The inputs “feed price” and “cost of vaccine” had minor effects on the output, in all pre-vaccination mortality scenarios. Although our simulations are based on conservative values and consider uncertainty about the modeled parameters, we conclude that vaccination against S. agalactiae is likely to be profitable in Nile tilapia farms, under similar production conditions.

Original languageEnglish (US)
Pages (from-to)131-135
Number of pages5
JournalPreventive Veterinary Medicine
Volume162
DOIs
StatePublished - Jan 1 2019
Externally publishedYes

Fingerprint

Cichlids
Oreochromis niloticus
economic valuation
Brazil
Vaccination
vaccination
Economics
Streptococcus agalactiae
farms
feed prices
Mortality
vaccines
Cost-Benefit Analysis
Fishes
serotypes
Vaccines
feed conversion
input prices
Combined Vaccines
Costs and Cost Analysis

Keywords

  • Brazil
  • Nile tilapia
  • Partial budget
  • Stochastic model
  • Streptococcus agalactiae
  • Vaccination

ASJC Scopus subject areas

  • Food Animals
  • Animal Science and Zoology

Cite this

Delphino, M. K. V. C., Barone, R. S. C., Leal, C. A. G., Figueiredo, H. C. P., Gardner, I., & Gonçalves, V. S. P. (2019). Economic appraisal of vaccination against Streptoccocus agalactiae in Nile tilapia farms in Brazil. Preventive Veterinary Medicine, 162, 131-135. https://doi.org/10.1016/j.prevetmed.2018.12.003

Economic appraisal of vaccination against Streptoccocus agalactiae in Nile tilapia farms in Brazil. / Delphino, Marina K.V.C.; Barone, Rafael S.C.; Leal, Carlos A.G.; Figueiredo, Henrique C.P.; Gardner, Ian; Gonçalves, Vítor S.P.

In: Preventive Veterinary Medicine, Vol. 162, 01.01.2019, p. 131-135.

Research output: Contribution to journalArticle

Delphino, Marina K.V.C. ; Barone, Rafael S.C. ; Leal, Carlos A.G. ; Figueiredo, Henrique C.P. ; Gardner, Ian ; Gonçalves, Vítor S.P. / Economic appraisal of vaccination against Streptoccocus agalactiae in Nile tilapia farms in Brazil. In: Preventive Veterinary Medicine. 2019 ; Vol. 162. pp. 131-135.
@article{55ed00a4671a47739a8781d8fa24e003,
title = "Economic appraisal of vaccination against Streptoccocus agalactiae in Nile tilapia farms in Brazil",
abstract = "Infection with Streptococcus agalactiae causes mortality and major economic losses in Nile tilapia (Oreochromis niloticus) farming worldwide. In Brazil, serotype strains Ia, Ib and III have been isolated in streptococcosis outbreaks, but serotype Ib is the most prevalent. Vaccination is considered an effective method to prevent economically-important diseases in aquaculture and has been associated with decreased use of antibiotics and improvements in fish survival. We developed a flexible partial-budget model to undertake an economic appraisal of vaccination against Streptococcus agalactiae in Nile tilapia farmed in net cages in large reservoirs. The model considers the benefits and costs that are likely to be associated with vaccination at the farm-level, in one production cycle. We built three epidemiological scenarios of cumulative mortality attributable to S. agalactiae (5{\%}, 10{\%}, and 20{\%}, per production cycle) in a non-vaccinated farm. For each scenario, we applied a stochastic model to simulate the net return of vaccination, given a combination of values of “vaccine efficacy” “gain in feed conversion ratio” “feed price” “fish market price “ and “cost of vaccine dose”. In the 20{\%} cumulative mortality scenario, the net return would break-even (benefits ≥ costs) in at least 97.9{\%} of interactions. Should cumulative mortality be lower than 10{\%}, the profitability of vaccination would be more dependent on better feed conversion ratio. The inputs “feed price” and “cost of vaccine” had minor effects on the output, in all pre-vaccination mortality scenarios. Although our simulations are based on conservative values and consider uncertainty about the modeled parameters, we conclude that vaccination against S. agalactiae is likely to be profitable in Nile tilapia farms, under similar production conditions.",
keywords = "Brazil, Nile tilapia, Partial budget, Stochastic model, Streptococcus agalactiae, Vaccination",
author = "Delphino, {Marina K.V.C.} and Barone, {Rafael S.C.} and Leal, {Carlos A.G.} and Figueiredo, {Henrique C.P.} and Ian Gardner and Gon{\cc}alves, {V{\'i}tor S.P.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.prevetmed.2018.12.003",
language = "English (US)",
volume = "162",
pages = "131--135",
journal = "Preventive Veterinary Medicine",
issn = "0167-5877",
publisher = "Elsevier",

}

TY - JOUR

T1 - Economic appraisal of vaccination against Streptoccocus agalactiae in Nile tilapia farms in Brazil

AU - Delphino, Marina K.V.C.

AU - Barone, Rafael S.C.

AU - Leal, Carlos A.G.

AU - Figueiredo, Henrique C.P.

AU - Gardner, Ian

AU - Gonçalves, Vítor S.P.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Infection with Streptococcus agalactiae causes mortality and major economic losses in Nile tilapia (Oreochromis niloticus) farming worldwide. In Brazil, serotype strains Ia, Ib and III have been isolated in streptococcosis outbreaks, but serotype Ib is the most prevalent. Vaccination is considered an effective method to prevent economically-important diseases in aquaculture and has been associated with decreased use of antibiotics and improvements in fish survival. We developed a flexible partial-budget model to undertake an economic appraisal of vaccination against Streptococcus agalactiae in Nile tilapia farmed in net cages in large reservoirs. The model considers the benefits and costs that are likely to be associated with vaccination at the farm-level, in one production cycle. We built three epidemiological scenarios of cumulative mortality attributable to S. agalactiae (5%, 10%, and 20%, per production cycle) in a non-vaccinated farm. For each scenario, we applied a stochastic model to simulate the net return of vaccination, given a combination of values of “vaccine efficacy” “gain in feed conversion ratio” “feed price” “fish market price “ and “cost of vaccine dose”. In the 20% cumulative mortality scenario, the net return would break-even (benefits ≥ costs) in at least 97.9% of interactions. Should cumulative mortality be lower than 10%, the profitability of vaccination would be more dependent on better feed conversion ratio. The inputs “feed price” and “cost of vaccine” had minor effects on the output, in all pre-vaccination mortality scenarios. Although our simulations are based on conservative values and consider uncertainty about the modeled parameters, we conclude that vaccination against S. agalactiae is likely to be profitable in Nile tilapia farms, under similar production conditions.

AB - Infection with Streptococcus agalactiae causes mortality and major economic losses in Nile tilapia (Oreochromis niloticus) farming worldwide. In Brazil, serotype strains Ia, Ib and III have been isolated in streptococcosis outbreaks, but serotype Ib is the most prevalent. Vaccination is considered an effective method to prevent economically-important diseases in aquaculture and has been associated with decreased use of antibiotics and improvements in fish survival. We developed a flexible partial-budget model to undertake an economic appraisal of vaccination against Streptococcus agalactiae in Nile tilapia farmed in net cages in large reservoirs. The model considers the benefits and costs that are likely to be associated with vaccination at the farm-level, in one production cycle. We built three epidemiological scenarios of cumulative mortality attributable to S. agalactiae (5%, 10%, and 20%, per production cycle) in a non-vaccinated farm. For each scenario, we applied a stochastic model to simulate the net return of vaccination, given a combination of values of “vaccine efficacy” “gain in feed conversion ratio” “feed price” “fish market price “ and “cost of vaccine dose”. In the 20% cumulative mortality scenario, the net return would break-even (benefits ≥ costs) in at least 97.9% of interactions. Should cumulative mortality be lower than 10%, the profitability of vaccination would be more dependent on better feed conversion ratio. The inputs “feed price” and “cost of vaccine” had minor effects on the output, in all pre-vaccination mortality scenarios. Although our simulations are based on conservative values and consider uncertainty about the modeled parameters, we conclude that vaccination against S. agalactiae is likely to be profitable in Nile tilapia farms, under similar production conditions.

KW - Brazil

KW - Nile tilapia

KW - Partial budget

KW - Stochastic model

KW - Streptococcus agalactiae

KW - Vaccination

UR - http://www.scopus.com/inward/record.url?scp=85058124862&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058124862&partnerID=8YFLogxK

U2 - 10.1016/j.prevetmed.2018.12.003

DO - 10.1016/j.prevetmed.2018.12.003

M3 - Article

VL - 162

SP - 131

EP - 135

JO - Preventive Veterinary Medicine

JF - Preventive Veterinary Medicine

SN - 0167-5877

ER -